Pharma Veterans

The REMDESIVIR Trials – Blog Post #347 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #347 . Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large . Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here .   Remdesivir is a broad-spectrum antiviral compound developed by Gilead Sciences USA. It is to be given by injection into a vein. The initial studies identified activity against several RNA viruses, however, Remdesivir was not approved for any indication. Remdesivir was originally developed to treat Hepatitis C where Gilead already had great victories with Sofosbuvir and combinations. It was also tested against Ebola virus and Marburg virus disease but was found to be ineffective against all of these. Lately, Remdesivir has been tried in COVID19 in several trials. Here is how ...

Dear Colleagues!   Today is Pharma Veterans Blog Post #134. Pharma Veterans shares your wealth of knowledge and wisdom with others for the benefit of entire Pharma Community. It aims to recognize and celebrate the Pharma Industry Professionals.  Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site.  Please share your stories, ideas and thoughts. Please email to asrar@asrarqureshi.com for publishing your contributions here . Business Development – What kind of products to look for? This is an interesting area. And a critically important one. BD persons may have a different view as compared to others in the organization. As they travel to various exhibitions and forums, they see many innovative and novel products. Some of these are really tempting. And there may be instances where BD may try to push some product(s) which they find very appealing, but which may not be compatible with the organizational n...